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Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United KingdomABSTRACT The extent to which Rhodopsin family G-protein-coupled receptors (GPCRs) form invariant oligomers is conten-
tious. Recent single-molecule fluorescence imaging studies mostly argue against the existence of constitutive receptor dimers
and instead suggest that GPCRs only dimerize transiently, if at all. However, whether or not even transient dimers exist is not
always clear due to difficulties in unambiguously distinguishing genuine interactions from chance colocalizations, particularly
with respect to short-lived events. Previous single-molecule studies have depended critically on calculations of chance colocal-
ization rates and/or comparison with unfixed control proteins whose diffusional behavior may or may not differ from that of the
test receptor. Here, we describe a single-molecule imaging assay that 1) utilizes comparisons with well-characterized control
proteins, i.e., the monomer CD86 and the homodimer CD28, and 2) relies on cell fixation to limit artifacts arising from differences
in the distribution and diffusion of test proteins versus these controls. The improved assay reliably reports the stoichiometry of
the Glutamate-family GPCR dimer, g-amino butyric acid receptor b2, whereas two Rhodopsin-family GPCRs, b2-adrenergic re-
ceptor and mCannR2, exhibit colocalization levels comparable to those of CD86 monomers, strengthening the case against
invariant GPCR oligomerization.INTRODUCTIONAdvances in fluorescence microscopy now allow the routine
detection and tracking of individual fluorescently labeled
proteins at the cell surface, e.g., using techniques such
as single-molecule total internal reflection fluorescence
(smTIRF) microscopy. Single-molecule imaging is particu-
larly attractive for the study of protein stoichiometry, as it
allows direct visualization of protein-protein interactions,
obviating the need for interpreting stoichiometry from indi-
rect assays.
Two general approaches have been taken. The first is
based on labeling with a single fluorophore and using
photobleaching-step counting or intensity analysis to deter-
mine protein stoichiometry (1–4), which can be combined
with selective photobleaching to achieve improved resolu-
tion (5). The second approach uses the labeling of proteins
with two spectrally distinct fluorophores and detecting co-
localization events to count the number of associated mole-
cules (6,7). In both cases, there are issues that need to be
addressed concerning the efficiency of protein labeling
and how this is taken into account in the analysis, and there
is also the problem of apparent association, which arises dueSubmitted February 20, 2015, and accepted for publication September 8,
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0006-3495/15/11/1798/9to two molecules being in close spatial proximity by chance.
The likelihood of chance association is usually estimated
from the protein density assuming that diffusion is random,
which may or may not be the case (8,9).
An alternative approach is to compare the behavior of the
protein of interest with that of proteins of known stoichiom-
etry, i.e., monomeric and dimeric controls. This establishes
the maximum and minimum levels (the dynamic range) of
signal expected in the experiment, taking account of labeling
efficiency and nonrandom diffusion. This approach proved to
be especially useful for the single-molecule video-based
analysis of the stoichiometry of the T-cell receptor (5),
wherein the cytoskeleton contributed a large fraction of the
measured coincidence by apparently constraining receptor
diffusion. A potential difficulty exists, however, in that the
control proteins may have intrinsically different diffusive
behavior versus the proteins of interest, in which case direct
comparisons utilizing video-based molecule tracking could
be problematic. The type of problem that could arise is illus-
trated in Fig. S1 in the Supporting Material. Such effects can
be avoided, however, if the proteins are fixed, as the variable
of diffusion is removed and an effective snapshot of receptor
oligomerization propensity can be obtained (Fig. S1).
A field of inquiry in which single-molecule microscopy
has been especially influential is the analysis of G-protein-
coupled receptor (GPCR) stoichiometry, which is argu-
ably the single most contentious aspect of their biology.
Smaller-family GPCRs, e.g., the Glutamate family (10),
are known to dimerize through large N- and C-terminalhttp://dx.doi.org/10.1016/j.bpj.2015.09.004
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numerous and pharmacologically important GPCRs, i.e.,
the receptors comprising the Rhodopsin family, are vigor-
ously disputed. This is an important matter, because in the
few studies in which it was examined in single-molecule
fluorescence experiments, receptor agonists had no discern-
ible effect on receptor stoichiometry (reviewed by Kasai and
Kusumi (11)). This suggests that any requirement for recep-
tor oligomerization as such might already be met before
activation of the receptor. Although it is known that several
Rhodopsin family receptors can function autonomously, i.e.,
as isolated monomers (12–14), they are nonetheless pro-
posed to form functionally distinct dimeric and oligomeric
complexes. Early claims for constitutive Rhodopsin-family
GPCR oligomerization were based on resonance energy
transfer (RET) measurements and coimmunoprecipitation
analyses, as well as on ostensibly cooperative receptor
behavior, but these conclusions have often been disputed
(15–18). More recently, single-molecule measurements
have challenged the general model of constitutive dimeriza-
tion, after consistently failing to demonstrate the required
levels of receptor oligomerization in transfected and native
cells (3,6,19), with just one exception (2). These studies
have instead reported levels of transient receptor association
above those expected by chance, leading to the constitutive
dimer model being supplanted by another comprised of tran-
sient dimerization (20). It is uncertain, however, whether the
measured signals were the product of genuine interactions
or instead reflected difficulties in calculating the nonspecific
background signal. The real extent of GPCR dimerization is
therefore unresolved.
In this study, we circumvent the issues inherent in single-
molecule imaging-based stoichiometric analysis by 1) utiliz-
ing well-characterized control proteins, i.e., the monomer
CD86 (16) and the homodimer CD28 (21), to establish the dy-
namic range of the experiment, and 2) relying on cell fixation
to limit artifacts arising from differences in the distribution
and diffusion of test proteins versus our control proteins. We
show that the improved assay reliably reports the stoichiom-
etry of the Glutamate-family GPCR dimer g-amino butyric
acid receptor b2 (GABAbR2),whereas twoRhodopsin-family
GPCRs, b2-adrenergic receptor (b2AR) and mCannR2,
exhibit colocalization levels comparable to those of CD86,
arguing against invariant GPCR oligomerization.TABLE 1 Transfection conditions used to obtain optimal
conditions for imaging
Protein Cell Line
Halo-Tagged
Construct (mg)
SNAP-tagged
Construct (mg)
Posttransfection
Incubation (h)
CD86 HEK-293T 0.975 0.025 7.0
CD28 HEK-293T 0.975 0.025 5.0
mCannR2 HEK-293T 0.975 0.150 4.0
GABAbR2 HEK-293T 0.975 0.080 42.0
b2AR HEK-293T 1.500 0.300 4.0
CD86 CHO-K1 0.975 0.175 20.0
CD28 CHO-K1 0.975 0.175 48.0
b2AR CHO-K1 0.975 0.080 18.5MATERIALS AND METHODS
Construct design and molecular cloning
Two expression vectors, pHRI-SNAP and pHRI-Halo, were generated from
the previously described pHRI-Citrine3 vector (7) by replacement of the
three constituent Citrine genes with those encoding either SNAP-tag or
HaloTag using flanking BamHI and NotI restriction endonuclease sites.
The new vectors encoded the SNAP-tag or HaloTag proteins at the C-termi-
nus of proteins of interest encoded by genes inserted into the upstream mul-
tiple cloning site. In both pHRI vectors, expression of inserted genes isunder the control of the ecdysone-dependent minimal heat-shock promoter
from the pCFB-EGSH vector (Agilent Technologies, Santa Clara, CA) such
that gene expression is limited to ~2000–4000 per cell in the absence of
ecdysone or equivalent analogs. Genes encoding CD86, CD28, GABAbR2,
mCannR2, and b2AR were subcloned from preexisting constructs
(described in James et al. (16)) by ligation into pHRI-SNAP or pHRI-
Halo after digestion with the following restriction endonucleases: CD86,
MluI þ AgeI; CD28, EcoRI þ BamHI; GABAbR2, MluI þ KpnI;
mCannR2, MluI þ BamHI; and b2AR, MluI þ BamHI. The integrity of
all constructs was confirmed by direct sequencing.Cell culture and plating
Human embryonic kidney (HEK)-293T cells were grown in DMEM supple-
mented with 10% fetal calf serum, 1% L-glutamine, and 1% antibiotics
(Life Technologies, Carlsbad, CA). Chinese hamster ovary (CHO)-K1 cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal calf serum, 1% antibiotics, 1% L-glutamine, 1% so-
dium pyruvate, and 2% supplement solution (70 mg adenosine, 70 mg
cytidine, 70 mg guanosine, 70 mg uridine, 24 mg thymidine, 20 mg aspar-
agine, 20 mg glutamic acid, and deionized H2O to a 200 mL final volume).
HEK-293T/CHO-K1 cells were plated in their respective media 24 h before
transfection in six-well plates at 3.0  105 cells/mL, 2 mL/well.Transfection
Constructs were cotransfected at a given ratio of the vectors encoding the
HaloTag- and SNAP-tag-labeled proteins using GeneJuice (Novagen,
Madison, WI) as per the manufacturer’s instructions. The ratio of tagged
constructs and the incubation times were optimized for each gene to achieve
densities of 100–1000 HaloTag spots per cell, and a SNAP-tag/HaloTag
ratio of 1–6, as given in Table 1.Labeling
A stock solution of HaloTag TMR Ligand (Promega, Madison, WI) was
diluted in supplemented DMEM to a final concentration of 5 nM. After in-
cubation posttransfection, all medium was removed from the cells and re-
placed with supplemented DMEM containing 5 nM HaloTag TMR
Ligand (Promega) and 5 mM SNAP-Cell 505-Star (New England Biolabs,
Ipswich, MA) before incubation for 30 min at 37C. Cells were then
washed with 3  1 mL medium and incubated for an additional 30 min
in 1 mL of medium before a final wash with 3  1 mL medium.Sample preparation for microscopy
Microscope coverslips were plasma cleaned (PDC-002, Harrick Plasma,
Ithaca, NY) in an argon atmosphere for 30 min before subsequent coatingBiophysical Journal 109(9) 1798–1806
1800 Latty et al.with poly-L-lysine-grafted polyethyleneglycol (PLL-g-PEG, SuSoS) for
45 min. Slides were then washed in duplicate with filtered (0.22 mm
Millex-GP syringe filter unit, Millipore, Billerica, MA) phosphate-buffered
saline (PBS, Life Technologies). After labeling and washing, cells were
mechanically removed and centrifuged at 2000 rpm for 2 min. The
resultant supernatant was removed and cells were resuspended in 200 mL
DMEM before being added onto coated cover slides. The plated cells
were then allowed to settle at 37C for 20 min. Medium on cover
slides was then replaced with 4% formaldehyde solution (16% w/v stock
solution (Thermo Fisher Scientific, Waltham, MA) diluted to 4% with
PBS). The formaldehyde solution was left on the plated cells for 1 h at
room temperature before replacement with PBS immediately preceding
imaging.smTIRF microscopy experimental set-up
The samples were imaged using smTIRF microscopy. Solid-state lasers
operating at 488 nm (Cyan, Petaluma, CA, and Spectra Physics, Santa
Clara, CA) and 561 nm (Excelsior-561-20-CDRH, Spectra Physics) were
used for the imaging, using a quarter-wave plate to ensure that the beams
were circularly polarized. Both beams entered the microscope on the
edge of the back focal plane of a 1.45 NA TIRF objective (60 Plan Apo
TIRF, NA 1.45, Nikon, Tokyo, Japan) mounted on a Nikon TE2000-U
microscope. A dichroic mirror (490575DBDR, Omega Optical, Brattle-
boro, VT) separated the collected fluorescence from the returning TIR
beam. The fluorescence signal was then split into red and yellow compo-
nents (585 DXLR, Omega Optical) and filtered using Dual-ViewTM
(Optical Insights, Suwanee, GA) mounted filters.
Images were acquired on an electron-multiplying charge-coupled device
equipped with a dual-view imaging system (Cascade IIþ DV2:512, Prince-
ton Instruments, Trenton, NJ), with the device split such that each color was
recorded on one-half of the device (70C; dichroic: DV2 FF562-Di03,
Semrock, Rochester, NY). Data acquisition was performed using Micro-
manager Software, version 1.4.13. Image stacks were recorded over 400
frames with exposure set at 35 ms. The operating power densities for the
488 nm and 561 nm lasers used to acquire data sets were 1.66 W cm2
and 5.19 W cm2, respectively.Colocalization analysis
Spots were identified from image stacks using a previously published
custom algorithm (22). Briefly, fluorescent puncta are superlocalized in
each frame of an input TIFF file after calculation of their respective inten-
sity-weighted centers of mass (centroids). Spatial coordinates are then
connected in subsequent frames with their nearest neighbors so that anal-
ysis can be performed on molecules that are fluorescent for multiple
frames. Fluorescence intensity thresholds are determined such that an
optimum number of puncta are detected in both spectral channels before
implementation of the colocalization analysis. This was empirically deter-
mined to be five standard deviations above the mean background for the
HaloTag TMR channel and three standard deviations over the mean back-
ground for the SNAP-Cell 505-Star signal in the experiments described
here.Diffusional analysis
As reported by others (23), we found that a small fraction of molecules (typi-
cally <6%) are still mobile after fixation of the cells (D R 0.2 mm2 s1).
Diffusion coefficients for individual proteins were determined from the
measurement of the position of the puncta with time to determine what frac-
tion are mobile and immobile using a mean-square displacement (MSD)
analysis (22). This small fraction of mobile events was prevented from
contributing to the coincidence calculation by collecting multiple framesBiophysical Journal 109(9) 1798–1806and applying a minimum frame criterion to the coincidence metric (see
Colocalization criterion below).Positional and registration accuracy
Our estimate of the positional accuracy is based on the standard deviation of
the temporal positions of our detected fluorophores. Our mean positional
accuracy was found to be 445 22 nm (mean5 SD) for the yellow channel
(HaloTag TMR ligand) and 385 21 nm for the blue channel (SNAP-Cell
505-Star). The image registration error refers to the alignment of the two
color channels (offset by 256 pixels horizontally and 0 pixels vertically).
To minimize registration error, an alignment procedure was followed
involving use of a custom-made regularly spaced grid with ion-beam-
etched holes in gold on glass. White-light illumination of the grid allowed
adjustment of dual-view optics such that overlap between red and green im-
ages was optimal. By adjusting the holes such that they appeared overlaid, a
calculation of the image registration error was undertaken using a bespoke
MATLAB-implemented algorithm. The mean image registration error for
the obtained data sets was 158 nm.Colocalization criterion
The colocalization criterion can be calculated by summing the root mean
square of the calculated positional accuracies in each channel, given by
the formula
st ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
sred2 þ sgreen2
p
:
To obtain a 90% probability of colocalization, we apply a distance
threshold of 1.65 st (24). Adding our value for the image registration ac-curacy, this gives us a colocalization distance value of 217 nm. To allow
for this, colocalization fractions are reported at 300 nm. This ensures that
the values we report are most likely to be true colocalization events. Selec-
tion of a 300 nm threshold also ensures that any error in our accuracy esti-
mates will not influence the reliability of the colocalization values. Our
conclusions were unaffected by the distance criteria used, although the
coincidence values increased as the distance criterion increased (Fig. S5),
as expected.
A minimum-frame (MF) criterion was also applied to the data. The MF
value is a function incorporated into the colocalization program, which is
defined as the minimum number of frames required for two fluorophores
to remain associated before being classed as coincident and removes the
contribution of noise from the data. The MF criterion also prevents the
small fraction of mobile spots from contributing to the analysis, since
the probability of two nonassociated fluorophores remaining within the co-
localization distance for multiple frames is low. In this case, the MF value
was set to 10. Assigning an MF value of 10 did not impede the detection of
coincidence, as determined using a subset of data from four cells expressing
GABAbR2 (1653 HaloTag spots and 4381 SNAP-tag spots in total), which
gave a consistent actual coincidence value of 15.6% using MF values be-
tween 1 and 10.Calculation of coincidence
The coincidence value was calculated relative to the total number of fluo-
rescent HaloTag spots for each cell. The total number of spots for which
coincident SNAP-tag and HaloTag fluorescence was detected, NSNAP-Halo,
was divided by the sum of the coincident and noncoincident Halo Tag spots,
NSNAP-Haloþ NHalo to give the reported coincidence value using the formula
Coincidence value ¼ NSNAP-Halo=ðNSNAP-Halo þ NHaloÞ:
The coincidence value for each cell was then used to calculate the mean
coincidence per cell and mean 5 SE values.
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To estimate labeling efficiency directly, CD86-HaloTag- or CD86-SNAP-
tag-transfected HEK-293T cells were stained with mouse anti-CD86 mono-
clonal IgG1 (clone BU63, VWR International, Radnor, PA). The antibody
was first conjugated to either AlexaFluor488 or AlexaFluor647 using anti-
body-labeling kits (Life Technologies), after which the conjugation effi-
ciency was assessed spectroscopically. The mean labeling efficiency for
AlexaFluor488 was 3.1 dye molecules/antibody, and 2.9 dye molecules/
antibody for AlexaFluor 647. Cell staining was performed after labeling
with SNAP-tag and HaloTag ligands at an antibody concentration of
100 mg/mL in ice-cold PBS for 45 min. Cells were then washed three times
with 1.5 mL cold PBS before being transferred to cover slides and fixed as
described above. Coincidence was then measured between the fluorescent
antibody spots and SNAP-tag or HaloTag spots as an estimate of labeling
efficiency (Fig. S4). HaloTag labeling efficiency was in this way estimated
to be ~33%, and SNAP-tag labeling efficiency ~16%.Calculation of labeling levels for CD28 based on
the coincidence level
It is possible also to calculate the labeling efficiencies for SNAP-tag and
HaloTag that would be required to achieve a certain level of CD28 coinci-
dence at a given ratio of fluorescent SNAP-tag:HaloTag spots. This allows
us to independently estimate the labeling efficiencies and to confirm that the
efficiencies measured using antibody coincidence are consistent with
observed CD28 coincidence.
Two factors determine the coincidence level relative to fluorescent
HaloTag spots: the labeling efficiency of both SNAP-tag and HaloTag
and the relative numbers of each tag at the cell surface. If we let the fraction
of CD28 protomers fused to SNAP-tag be n and the fraction fused to
HaloTag m, then n þ m ¼ 1. If the labeling efficiencies of SNAP-tag and
HaloTag are defined as p and q, respectively, then the expected coincidence
value relative to fluorescent HaloTag spots (c) is given by the equation (see
the Supporting Discussion for the full derivation)
HaloTag coincidence ¼ c ¼ 2np
2nþ 2m mq:
n and m can be determined using the labeling efficiencies p and q as well as
the observed ratio of fluorescent SNAP-tag/HaloTag spots, given by f,through the relationship
f ¼ np
mq
:
Using the known values for c and f, it is therefore possible to calculate the
expected values for p and q. To do this, it is necessary to estimate the rela-tive efficiencies of SNAP-tag and HaloTag labeling. In the simplest model,
the labeling efficiencies are assumed to be equal, and hence, p ¼ q. In
this case,
p ¼ q ¼ 2c
2þ cm 2m
andm ¼ 1

f
ð1þ f Þ

(see the Supporting Discussion for the full derivation). For CD28 in HEK-
293T cells, c ¼ 0.17 and f ¼ 3.23, which suggests a labeling efficiency of
22% for both SNAP-tag and HaloTag if both are assumed to be equal. Simi-
larly, for CD28 in CHO-K1 cells, c ¼ 0.28 and f¼ 3.27, indicating labeling
efficiencies of 36%.The labeling efficiency values can also be calculated assuming that
HaloTag labeling efficiency is twice that of SNAP-tag labeling, as indicated
by direct measurement of labeling efficiency through antibody staining. In
this model, 2p ¼ q, and hence,
p ¼ c
1þ cm m
and  
m ¼ 1 2fð1þ 2f Þ
(see the Supporting Discussion for the full derivation). Using the same
values for c and f as above, this model gives an estimate of 19% SNAP-tag and 38% Halo-Tag labeling in HEK-293T cells, and 31% SNAP-tag
and 62% Halo-Tag labeling in CHO-K1 cells.
The labeling efficiency valuesmeasured using antibody labeling (p¼ 0.16,
q¼ 0.33) in HEK-293T cells can be combined with the observed SNAP-tag/
HaloTag ratio (f ¼ 3.23) to determine expected coincidence. This gives
an expected coincidence of 14.2%, which is close to the observed value of
16.9%, indicating that our estimates of labeling efficiency are reasonable.Estimation of sensitivity
The minimum level of dimerization detectable in this assay can be esti-
mated by determining the minimum difference between the sample mean
coincidence and the mean coincidence for CD86 required for statistical sig-
nificance taking into account the measured mean 5 SE values for each
sample, which is expressed as the t-statistic,
t ¼ xsample  xCD86ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mean 5 SE2sample þmean 5 SE2CD86
q :
This can then be expressed as percent coincidence by normalization
against the mean difference between CD86 and CD28, which represent 0and 100% dimerization, respectively.
Fraction dimers required for detection ¼ xsample  xCD86
xCD28  xCD86
¼
t
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
mean 5 SE2sample þmean 5 SE2CD86
q
xCD28  xCD86 :
RESULTS
The improved single-molecule fluorescence-based stoichio-
metric assay utilizes comparisons with well-characterized
monomeric and dimeric control proteins, i.e., CD86 and
CD28, and cell fixation to limit artifacts arising from differ-
ences in the distribution and diffusion of given test proteins
versus these controls (Fig. S1). Proteins are transiently ex-
pressed in HEK-293T or CHO-K1 cells as chimeras with
either SNAP-tags (25) or HaloTags (26) for organic fluoro-
phore labeling at the (intracellular) C-terminus (Fig. 1, A
and C). Transient transfection ensures that the lower surface
expression levels (typically 0.1–1 receptors/mm2) required
to minimize random colocalization are achievable, and
C-terminal labeling avoids difficulties we have experienced
with the folding and trafficking of some N-terminally taggedBiophysical Journal 109(9) 1798–1806
FIGURE 1 Principle of referenced colocaliza-
tion exemplified for CD86 and CD28 controls ex-
pressed in HEK-293T cells. (A) Representation of
transfected HaloTag- (red) and SNAP-tag (green)-
labeled monomeric CD86 protein. (B) Representa-
tive data obtained for CD86 in the green and red
channels showing raw data (top row) and recon-
structions of spot detection after application of the
tracking algorithm (bottom row). Blue-boxed re-
gions are shownmagnified at far right. (C) HaloTag-
(red) and SNAP-tag-labeled (green) dimeric CD28
protein. (D) Representative raw and reconstructed
data obtained for CD28 showing higher levels of
coincidence. Scale bars are 5 mm.
1802 Latty et al.GPCRs (data not shown). The labeled proteins are imaged in
fixed cells for 400 frames with an exposure time of 35 ms,
after which individual fluorescent puncta are identified us-
ing a custom algorithm (22). Multiple frames are collected
to exclude the small fraction of residual mobile proteins
that would otherwise bias the measurements of coincidence.
Fixation is generally highly effective at reducing the move-
ment of the majority of fluorescent objects to levels compa-
rable with those of glass-immobilized SNAP-tag and
HaloTag ligands (Fig. S2). Typically, <6% of spots on fixed
cells exhibited movement greater than that required to leave
the diffraction-limited starting position within 10 frames.
Representative examples of spot detection are given in
Figs. 1, B and D, 2 B, and 3 B.
In the experiments presented here, the number of SNAP-
tag fluorescent puncta was considerably larger than theBiophysical Journal 109(9) 1798–1806number of equivalent HaloTag fluorescent puncta, presum-
ably due to differences in folding and labeling efficiency.
Cells with a fluorescent SNAP-tag/HaloTag ratio in the
range 6–1 were used for data collection, and analysis was
limited to cells exhibiting 100–1000 individual HaloTag
diffraction-limited single emitters (Fig. S3 and Table 2).
Coincidence was calculated relative to the HaloTag channel
due to the lower densities of objects in this channel. Coin-
cident events are defined as spatially isolated, diffraction-
limited fluorescent HaloTag puncta that are within
300 nm of a fluorescent SNAP-tag spot. The distance crite-
rion is based on the positional accuracy for the red and blue
channel alignment, and the use of 10 frames ensures an
optimal signal/noise ratio. The results are not sensitive to
the distance criterion (Fig. S5) or number of frames (see
Materials and Methods) used to identify a coincident event.FIGURE 2 Referenced colocalization analysis
differentiates between GPCR oligomerization
states in HEK-293T cells. (A) Coincidence for
CD28 and GABAbR2, but not mCannR2 or
b2AR, is significantly larger (p > 0.05, two-tailed
t-test) than that measured for CD86. Values are
mean percentage coincidence 5 SE for data
from individual cells. (B) Representative images
showing fluorescence of GPCRs expressed in
HEK-293T cells, in the form of both raw data
(top) and reconstructed data after spot detection
(bottom). Equivalent images for CD86 and CD28
are given in Fig. 1. Red spots correspond to fluores-
cent HaloTag-labeled proteins and green spots to
fluorescent SNAP-tag-labeled proteins. Scale bars
are 5 mm.
FIGURE 3 Referenced colocalization analysis
reveals that b2AR does not behave as a dimer in
CHO-K1 cells. (A) The coincidence value for
b2AR is not significantly larger than that measured
for CD86. (B) Representative raw (top) and recon-
structed (bottom) data obtained for HaloTag- (red)
and SNAP-tag-labeled (green) CD86, CD28, and
b2AR expressed in CHO-K1 cells. Scale bars
are 5 mm.
GPCR Oligomerization States 1803HEK-293T cells were used initially to facilitate compar-
isons with our previous RET experiments (16,27). We first
established the dynamic range of the assay by measuring
the coincidence levels for the monomer control CD86 and
the dimer CD28 in these cells, and the values were 8.2 5
1.2% and 16.95 2.2%, respectively (Fig. 2 A; values given
are the mean 5 SE coincidence observed for individual
cells within a range of fluorescent SNAP-tag/HaloTag spot
ratio of 6:1 and 100–1000 fluorescent HaloTag events/
cell). The differences in these coincidence values are more
than sufficient to unambiguously distinguish between strict
monomers and dimers. Coincidence for CD86 results from
fluorescent HaloTag- and SNAP-tag puncta that, by chance,
are close enough to be recorded as a coincident event, which
depends simply on the density of fluorescent HaloTag- and
SNAP-tag puncta. However, if there is nonrandom diffusion
on the cell surface, e.g., due to the underlying cytoskeleton,
and hence a nonrandom spatial distribution of CD86, the
level of coincidence will be increased above that governed
by chance (5). We suspected that the reason the coincidence
level for CD28 was not higher was due to relatively low
labeling efficiencies. To directly measure the SNAP-tag
and HaloTag labeling efficiencies, we determined the levels
of coincidence for our fluorescently labeled SNAP-tag and
HaloTag CD86 constructs bound to fluorescently taggedTABLE 2 Number of analyzed cells and fluorescent spots, and stati
for each candidate protein
Protein Cell Line Cells Imaged
Noncoincident
HaloTag Spots
CD86 HEK-293T 13 4279
CD28 HEK-293T 7 2952
GABAbR2 HEK-293T 7 2844
mCannR2 HEK-293T 16 9166
b2AR HEK-293T 13 8132
CD86 CHO-K1 10 2797
CD28 CHO-K1 8 1626
b2AR CHO-K1 10 2497
Statistical probability of a difference was determined using a two-tailed t test. C
imaged.anti-CD86 antibodies. This showed that the labeling effi-
ciencies were ~33% for the HaloTag and ~16% for the
SNAP-tag (Fig. S4). The value of 16% for the SNAP-tag
labeling efficiency is comparable to the value of 21.2%
calculated from the coincidence level for CD28 (see Mate-
rials and Methods). This strongly suggests that it is
principally the labeling efficiency that limits the coinci-
dence value for the CD28 dimer control rather than issues
to do with spot detection. An important advantage of the
improved method, therefore, is that by establishing the dy-
namic range using control proteins, stoichiometry can be as-
signed without the need for 1) high labeling efficiencies,
which are technically very difficult to obtain, or 2) the
need to measure the labeling efficiency or the expression
levels of the constructs.
Having established the dynamic range of the assay, we
then compared the levels of coincidence obtained for
proteins of interest with those measured for the monomer
and dimer controls. The mouse Rhodopsin-family GPCR,
cannabinoid receptor 2 (mCannR2) exhibited a coincidence
level not significantly different from that of CD86, i.e.,
9.9 5 0.9% (Fig. 2). In contrast, the Glutamate-family
GABAbR2, which uses N-terminal domains to homodimer-
ize (2,16), exhibited a coincidence level comparable to that
of CD28, i.e., 17.75 3.9%, as expected (Fig. 2; the p-valuesstical probability of a difference from CD86 in the same cell line,
Coincident
HaloTag Spots % Coincidence5 SE
p-Value of Difference
from CD86
346 8.2 5 1.2 –
587 16.95 2.2 0.001
622 17.75 3.9 0.012
978 9.9 5 0.9 0.289
855 9.6 5 1.1 0.440
313 9.7 5 1.5 –
678 28.25 3.7 0.0001
334 12.15 1.7 0.325
oincidence values were determined as the mean coincidence for each cell
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Analysis of the same data using different distance criteria
to define coincidence did not affect the assignment of
mCannR2 or GABAbR2 stoichiometry on the basis of com-
parisons with CD86 or CD28 (Fig. S5 A). These data argue
against mCannR2 homodimerization, and they confirm that
the assay is capable of correctly identifying GPCR dimers.
We then extended the analysis to the prototypical
Rhodopsin family GPCR, b2AR, and this gave a coincidence
level of 9.6 5 1.1 in HEK-293T cells (Fig. 2), i.e., a level
that was very similar to that of mCannR2 and not signifi-
cantly different from that of the monomer control CD86.
This suggests that b2AR behaves as a monomer, consistent
with our previous RET-based analyses of this receptor in
these cells (13,24). An important caveat, however, is that
HEK-293T cells express low levels of native (unlabeled)
b2AR (28), which could have reduced the coincidence
signal due to competition effects.
To avoid this possibility, we performed the stoichiometric
analysis of b2AR again, this time in CHO-K1 cells, as these
cells do not have native human b2AR and do not cluster the
receptor (2,29), so that misidentification of clustered mono-
mers as dimers is less likely. This required the dynamic
range for these cells to be established, wherein CD86 and
CD28 yielded coincidence values of 9.7 5 1.5% and
28.2 5 3.7% (Fig. 3 D). As expected, the level of coinci-
dence for CD86 is unchanged versus that in HEK-293T
cells. Because the level and range of fluorescent HaloTag
and SNAP-tag spots to be used in the analyses have been
defined on a per-cell basis, the chance level of CD86 coin-
cidence will not vary from one cell type to another irrespec-
tive of expression level (the relationship between expression
level and labeling efficiency for monomers and dimers is
illustrated schematically in Fig. S6). The coincidence value
for CD28, however, is substantially higher than that ob-
tained in HEK-293T cells. This is readily explained by the
SNAP-tag labeling efficiency being higher in CHO-K1
cells, since 1) the coincidence level for dimers will be sen-
sitive to labeling efficiency and expression level (Fig. S6),
and 2) labeling efficiency is known to vary between different
cell types (see, e.g., Klein et al. (30)). Using the coincidence
value for CD28, we calculate that the SNAP-tag and
HaloTag labeling efficiencies were 31% and 62% (the calcu-
lations are given in Materials and Methods and the Support-
ing Discussion). These considerations once again emphasize
the importance of determining the dynamic range of the
assay using well-defined control proteins. The coincidence
value obtained for b2AR in CHO-K1 cells was not signifi-
cantly higher than for CD86 (12.15 1.7%; Fig. 3), consis-
tent once again with b2AR behaving as a monomer.
Changing the distance criterion used to define coincidence
did not affect the conclusions drawn on the basis of the
CHO-K1 measurements (Fig. S5 B).
Using the measured mean 5 SE values, it is possible to
estimate the degree of receptor dimerization that wouldBiophysical Journal 109(9) 1798–1806have been required to achieve significance in our assay
(see Materials and Methods). The level of dimerization of
mCannR2 required for 90% confidence is 29% (t ¼ 1.703,
27 degrees of freedom), and for b2AR, it is 32% in HEK-
293T cells (t ¼ 1.717, 22 degrees of freedom) and 21% in
CHO-K1 cells (t ¼ 1.734, 18 degrees of freedom). We can
therefore conclude that the dimerization of mCannR2 and
b2AR, if it occurs at all, cannot exceed these levels in our
assay. Indeed, for b2AR, even 16% dimerization would still
have been detectable with 80% confidence (t ¼ 1.33, 18 de-
grees of freedom), but this was not observed.DISCUSSION
We have demonstrated the utility of an improved single-
molecule imaging-based stoichiometric assay that is reliant
on comparisons with well-characterized control proteins
and incorporates cell fixation to limit artifacts arising from
variation in protein distribution and diffusion. This means
that we do not need to know the relative expression level
of the SNAP-tag and HaloTag constructs or their labeling
efficiencies. We demonstrate the ability of the assay to reli-
ably distinguish between GPCRs shown previously to
behave as dimers and monomers, and then use it to address
the stoichiometry of a more contentious receptor, b2AR.
A fundamental problem with the use of single-molecule
fluorescence-based methods to determine the oligomeriza-
tion state of proteins is that, generally, most methods used
to label the proteins with fluorophores are not 100% effi-
cient. This can be attributed to inefficient chemical reactions
in the case of SNAP-tag- or HaloTag-based labeling, or to
the failure of the protein to fold correctly into a fluorescent
state in the case of autofluorescent proteins (31). To address
this issue, new methods need to be found that increase the
labeling efficiency to close to 100% if possible, or else the
labeling efficiency and relative expression levels need to
be measured and taken into account in the analysis. How-
ever, it is generally quite difficult to measure labeling effi-
ciency and relative expression level. A key advantage over
older methods, to our knowledge, is that the new approach
does not require such measurements because the level of
coincidence of the protein of interest is directly compared
with the level of coincidence for well-characterized mono-
mer and dimer controls expressed in the same cell line.
Although we have used a two-color coincidence approach
to analyze our single-molecule data here, the same approach
based on monomer and dimer controls could in principle be
applied to intensity-based analyses of the data. The method
presented here therefore comprises, to our knowledge, a new
general approach for more accurately determining whether
proteins exist as monomers or dimers (and higher-order
oligomers) in the resting cell membrane. The assay could
in principle also be used to determine whether receptors
alter their stoichiometry after activation. However, addi-
tional technical issues arising from, e.g., internalization of
GPCR Oligomerization States 1805the receptor and the mode and timing of fixation would need
to be resolved to perform such experiments.
Our observations are consistent with b2AR, like
mCannR2, behaving as a monomer, in agreement with our
previous studies of these receptors using RET-based ap-
proaches (16,27), although we are unable to fully exclude
the possibility that small fractions of these receptors form
dimers. Although this provides only a partial insight into
the general behavior of Rhodopsin-family receptors, there
is at present no evidence suggesting that either b2AR or
mCannR2 are anomalous versus the behavior of Rhodopsin
family GPCRs generally. Although the stoichiometry of
mCannR2 has not been exhaustively studied, b2AR has
been the subject of numerous, often contradictory investiga-
tions. Some studies have shown that b2AR self-associates
upon solubilization (32–34), whereas feasible homodimers
are conspicuously absent in the lattices of all the published
b2AR crystal structures (35–37). Moreover, isolated b2AR
receptors can efficiently activate G-proteins (13,38), and
the receptor crystallizes in a stable 1:1 receptor/G-protein
complex (39). In marked contrast, early in situ analyses
utilizing RET were claimed to indicate the existence of
constitutive b2AR dimers (32,34,40,41), although the inter-
pretation of much of these data did appear to be problematic
(15,16,27), and subsequent RET approaches performed by
ourselves and others (42) have instead suggested that the
b2AR is monomeric. Similarly, assays based on the coin-
ternalization or coclustering of b2AR monomers also fail
to support the notion that this receptor oligomerizes (43,44).
Our improved single-molecule imaging-based assay
offers yet more support for b2AR behaving exclusively or
almost exclusively as a monomer. A previous single-mole-
cule-level investigation of b2AR (2) reported high levels
of receptor dimerization, and the reasons for this discrep-
ancy are unclear, as the experimental approaches used are
very different. Important differences include the use of
1) intensity analysis versus two-color coincidence, 2) live
versus fixed cells, 3) stable versus transient expression,
and 4) extracellular N-terminal labeling versus cytoplasmic
C-terminal labeling. The N-terminal regions of Rhodopsin-
family GPCRs undergo extensive interactions with extracel-
lular loops (45) and in some cases form disulfide bridges
that stabilize the loop orientation (46), implicating the
N-terminal regions in receptor folding. We have experi-
enced difficulties expressing N-terminally tagged GPCRs
and envisage that N-terminal labeling could result in partial
receptor misfolding and aggregation, influencing apparent
stoichiometry. In contrast, GPCR C-terminal domains are
more typically unstructured (47,48), and C-terminal tagging
of receptors is the general approach adopted by the field
(49). Our finding, i.e., that the b2AR does not appreciably
dimerize when C-terminally tagged, is consistent with pre-
vious single-molecule studies of GPCRs showing that these
receptors exhibit primarily monomeric behavior (3,6,19).
These observations suggest that at least some Rhodopsinfamily GPCRs are likely to be functionally monomeric,
and our improved assay will allow us to determine if this
is true for most of these receptors.SUPPORTING MATERIAL
Supporting Discussion and six figures are available at http://www.biophysj.
org/biophysj/supplemental/S0006-3495(15)00934-0.AUTHOR CONTRIBUTIONS
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